Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2025

Feb 12, 2025

29745_dirs_2025-02-12_4d508634-738f-4b97-9d7f-3a6b9fe88a5a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2025-02-10

Reporting Person: Zakrowski Donald A (SVP, Finance, & CAO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-10 Common Stock A 1359.659 $868.88 Acquired 6839.659 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-10 Restricted Stock Unit $ A 216.389 Acquired 2028-02-16 Common Stock (216.389) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1718.42 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.